IP RECEPTOR AGONIST HETEROCYCLIC COMPOUNDS
    1.
    发明公开
    IP RECEPTOR AGONIST HETEROCYCLIC COMPOUNDS 有权
    杂环化合物IP-REZEPTORAGONISTEN

    公开(公告)号:EP2593452A1

    公开(公告)日:2013-05-22

    申请号:EP11732449.1

    申请日:2011-07-14

    申请人: Novartis AG

    摘要: The present invention provides heterocyclic derivatives which activate the IP receptor. Activating the IP receptor signaling pathway is useful to treat many forms of PAH, pulmonary fibrosis and exert beneficial effects in fibrotic conditions of various organs in animal models and in patients. Pharmaceutical compositions comprising such derivatives are also encompassed.

    摘要翻译: 本发明提供活化IP受体的杂环衍生物。 激活IP受体信号通路可用于治疗多种形式的PAH,肺纤维化,并在动物模型和患者的各种器官的纤维化病症中发挥有益作用。 还包括包含这些衍生物的药物组合物。 本发明化合物的实例包括根据式Ia的化合物或其药学上可接受的盐,以及实施例的化合物。